This Article  • References  • Full text PDF  • Correction  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (31)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Sandra A. N. Tailor, PharmD
Department of Pharmacy Sunnybrook Health Science Centre University of Toronto 2075 Bayview Ave, E-300 North York, Ontario, Canada M4N 3M5

Aditya K. Gupta, MD, FRCPC; Scott E. Walker, MScPharm; Neil H. Shear, MD, FRCPC
North York

Arch Dermatol. 1996;132(3):350-352.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

We report a case of a drug interaction observed in a patient who was administered itraconazole for pedal onychomycosis and whose hypertension had been stabilized with nifedipine therapy. The patient spontaneously reported ankle edema with the drug combination and experienced a substantial elevation in serum nifedipine concentrations while receiving itraconazole.

Report of a Case.

A 68-year-old woman with pedal onychomycosis experienced ankle edema, for the first time, during pulse therapy with itraconazole, given as 200 mg orally twice daily for 1 week every month for a total of three courses. Her hypertension was controlled with nifedipine and atenolol (3 years). Other medications included medroxyprogesterone and conjugated estrogen (2.5 years) and vitamin preparations. Ankle edema developed during the first and second courses of itraconazole therapy, starting after 2 to 3 days of itraconazole therapy and resolving 2 to 3 days following discontinuation of itraconazole. She did not have ankle edema . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?